Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

ABSI vs MTLS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MTLS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–2 Matrix Metrics)

MTLS Overall Winner 6-Pillar Tally: ABSI 1 – 5 MTLS Matrix Metrics: ABSI 2 – 7 MTLS

As of Nov 17, 2026, Materialise NV (MTLS) is the stronger overall head-to-head candidate over Absci Corporation (ABSI) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABSI carries a Unified Composite Score of 50.8/100 (HOLD) at $7.58 (N/M Forward P/E, -9108.3% operating margin), whereas MTLS carries 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin).

  • Technical & Structure Timing Caution: ABSI is currently in a Breakdown options structure phase (RSI 38.4); meanwhile MTLS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 31.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABSI vs MTLS
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.58
+1.4% 1D
Market Cap $1.5B
TTM Revenue $1.5M
Forward P/E N/M
Beta / 30D Vol 3.31β · 126% Vol
Unified Composite Score
50.8 / 100 HOLD
Tech 50.0 Fund 56.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.4 · SMA20: $9.85 · SMA50: $9.60
MTLS NASDAQ Head-to-Head Winner
Materialise NV
Services-Prepackaged Software
$6.28
+1.13% 1D
Market Cap $369.9M
TTM Revenue $605M
Forward P/E N/M
Beta / 30D Vol 1.10β · 88% Vol
Unified Composite Score
53.5 / 100 HOLD
Tech 53.0 Fund 53.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 31
RSI-14: 31.4 · SMA20: $7.28 · SMA50: $7.78

6-Pillar Scorecard Institutional Category Breakdown (ABSI 1 – 5 MTLS)

Columns: Metric · ABSI · MTLS
1. Valuation Multiples MTLS
Forward P/E N/M N/M
Trailing P/E N/M 25.0x
PEG Ratio N/M 1.26x
EV / Revenue N/M 0.6x
2. Growth & Scale MTLS
Revenue Growth (YoY) -19.6% +2.1%
Earnings Growth (YoY) +0.0% -33.3%
TTM Revenue (USD) $1.5M $605M
Market Cap $1.5B $369.9M
3. Profitability & Quality MTLS
Gross Margin N/A 57.4%
Operating Margin -9108.3% 3.4%
Net Profit Margin 0.0% 4.6%
Return on Equity (ROE) -58.6% 5.0%
4. Balance Sheet & Cash Flow MTLS
Cash Generation (TTM) -$112M $55M EBITDA
Cash Flow Margin N/A 9.1% EBITDA Mgn
Net Cash / Leverage $10M Net Cash $4.97 Book/Sh · 5.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABSI
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 169.1% (15th %ile) N/A (N/A)
Put/Call OI Skew 1.21x (Put-Skewed) Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat MTLS
OpEx & R&D Intensity N/A 54.0% of Rev ($327M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABSI (2) vs MTLS (7)
Institutional Metric ABSI MTLS Criterion Row Edge
Market Capitalization
Scale
$1.5B $369.9M Larger Scale ABSI
Trailing P/E Ratio
Valuation
N/M 25.0x Lower Multiple MTLS
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-19.6% +2.1% Higher Growth MTLS
Operating Margin (TTM)
Profitability
-9108.3% 3.4% Higher Margin MTLS
Net Profit Margin
Profitability
0.0% 4.6% Higher Margin MTLS
Return on Equity (ROE)
Capital Efficiency
-58.6% 5.0% Higher ROE MTLS
52-Week Range Position
Momentum
52% ($2–$13) 37% ($5–$9) Stronger Trend ABSI
Beta / 30D Volatility
Risk Regime
3.31β · 126% Vol 1.10β · 88% Vol Lower Realized Risk MTLS
Unified Institutional Score
Composite Signal
50.8 / 100 (HOLD) 53.5 / 100 (HOLD) Higher Composite MTLS
Trailing 12M Revenue (USD)
Operating Scale
$1.5M $605M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 57.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.26x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$112M ($10M Net Cash) $55M EBITDA ($4.97 Book/Sh · 5.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABSI +11.28 pp
ABSI: -11.24% · MTLS: -22.52%
3M Horizon MTLS +19.71 pp
ABSI: -24.12% · MTLS: -4.41%
6M Horizon ABSI +50.76 pp
ABSI: +63.71% · MTLS: +12.95%
1Y Horizon ABSI +164.3 pp
ABSI: +168.79% · MTLS: +4.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABSI vs MTLS. Trailing 12-month operating profitability (ABSI -9108.3% vs MTLS 3.4%) and valuation multiples (ABSI N/M vs MTLS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ABSI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.5M
Gross MarginN/A
Op. Margin-9108.3%
ROE / Fwd P/E-58.6% · N/M
MTLS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$605M
Gross Margin57.4%
Op. Margin3.4%
ROE / Fwd P/E5.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABSI BREAKDOWN
98d in phase · OBV NEUTRAL
Current IV 169.1%
IV Percentile 15th %ile
Put/Call OI Skew 1.21x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABSI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MTLS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MTLS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABSI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.5B market capitalization and -9108.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
MTLS Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $369.9M market capitalization and 3.4% operating margin.
OpEx & R&D Reinvestment 54.0% of Rev ($327M)
90D Engineering Disclosures 0 Published

Investor FAQ ABSI vs MTLS Key Questions & Quantitative Answers

As of Nov 17, 2026, Materialise NV (MTLS) is the stronger overall head-to-head candidate over Absci Corporation (ABSI) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABSI carries a Unified Composite Score of 50.8/100 (HOLD) at $7.58 (N/M Forward P/E, -9108.3% operating margin), whereas MTLS carries 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin). Technical & Structure Timing Caution: ABSI is currently in a Breakdown options structure phase (RSI 38.4); meanwhile MTLS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 31.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MTLS leads the Growth & Scale pillar: ABSI posts -19.6% YoY revenue growth and +0.0% YoY earnings growth on $1.5M TTM revenue (N/A gross margin, -9108.3% operating margin), compared with MTLS at +2.1% YoY revenue growth and -33.3% YoY earnings growth on $605M TTM revenue (57.4% gross margin, 3.4% operating margin). On trailing 12-month operating scale, ABSI generates $1.5M in USD-normalized revenue versus $605M for MTLS. In operating R&D and SG&A reinvestment, ABSI deploys N/A (0 90-day corporate R&D disclosures) versus 54.0% of Rev ($327M) (0 disclosures) for MTLS.

MTLS screens cheaper on headline valuation multiples. ABSI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas MTLS trades at N/M Forward P/E, 25.0x Trailing P/E, 1.26x PEG, and 0.6x EV/Revenue (9.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABSI (-58.6% ROE) versus MTLS (5.0% ROE) capital efficiency.

In options market volatility and institutional positioning, ABSI carries 169.1% implied volatility (15th %ile, Compressed (<25th %ile)), a 1.21x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.31β · 126% Vol realized risk). By comparison, MTLS carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 88% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.